In January, the U-M Max Harry Weil Institute for Critical Care Research and Innovations was formally established through a $10M gift from the Weil family. Since then, we have grown exponentially. Let’s look back on and celebrate our first year as Weil.
Read MoreThe team will develop and validate a large animal model of cardiac arrest with resultant severe brain injury to translate new neuroprotective therapies.
Read MoreThe result of a major multi-departmental and multi-school collaboration, the investment will support the Weil Institute’s unique preclinical critical care lab to advance translational research in critical care over the next 5 years.
Read MoreThe Weil Institute Pre-Clinical Critical Care Laboratory (PC3L) is collaborating with medical device maker Abiomed, Inc. to examine the potential of using Abiomed Impella CP® left ventricular assist device as a resuscitative strategy for sudden cardiac arrest.
Read MoreMCIRCC’s objective is to transform critical care through innovation, integration, and entrepreneurship. But what does that mean and how is it being done? The MCIRCC Pre-Clinical Operative and Intensive Care Unit was created in February 2013 to embody this objective and has made great strides in high-risk, high-reward pursuits.
Read More
